Distribution of ANLN nuclear fraction with regard to tamoxifen treatment. Distribution of ANLN nuclear fraction was analyzed with regard to tamoxifen treatment in cohort II, a randomized prospective tamoxifen trial. The distribution of ANLN nuclear fraction was similar in the treatment and control arms with the majority of tumors expressing less than 25% of ANLN nuclear staining. (PDF 25 kb